Ada
Ada Abutbul, Zicron Yaqov IL
Patent application number | Description | Published |
---|---|---|
20090064410 | Method and device for rocking baby cribs, strollers and other objects on wheels - A motor with apparatus comprising a series of connected links to change the circular motion of the motor to a linear motion and from the linear motion to a continuous oscillation to and fro which motion is transferred to an arc shaped rocker cradle. A wheel of the stroller or other object sits in the rocker cradle and the stroller or other object is thereby rocked to and fro. | 03-12-2009 |
Ada Chen, Shanghai CN
Patent application number | Description | Published |
---|---|---|
20140176245 | OSCILLATOR AND SELF-CALIBRATION METHOD THEREOF - An oscillator and a self-calibration method thereof are provided. The oscillator includes: an oscillation unit for generating an oscillation signal; a converting unit for converting frequency of the oscillation signal into a voltage signal; a comparison unit for comparing the voltage signal with a first voltage corresponding to a higher frequency and a second voltage corresponding to a lower frequency, and outputting a comparison result signal; an adjusting unit for storing a calibration value, adjusting the calibration value based on the comparison result signal and outputting a calibration signal corresponding to the adjusted calibration value; and a calibration unit for calibrating the frequency of the oscillation signal based on the calibration signal. Self-calibration for the frequency of the oscillation signal may be achieved, which may ensure the stability of the frequency of the oscillation signal. | 06-26-2014 |
Ada Girnita, Taby SE
Patent application number | Description | Published |
---|---|---|
20140335077 | Compositions and Methods for the Treatment of Cancer Using IGF-IR Antagonists and MAPK/ERK Inhibitors - The present invention relates generally to the field of cancer therapy. More specifically the present invention relates a combination therapy where IGF-1R antagonists are combined with MAPK/ERK pathway inhibitors. The present invention relates to a therapeutic combination comprising an IGF-1R antagonist and a MAPK/ERK pathway inhibitor, and to methods for the production of an anti-cancer effect in a patient. The present invention relates to: a therapeutic combination comprising an IGF-1R antagonist and a MAPK/ERK pathway inhibitor; a combination product comprising an IGF-1R antagonist and a MAPK/ERK pathway inhibitor, a kit of parts comprising an IGF-1R antagonist and a MAPK/ERK pathway inhibitor; use of a therapeutic combination, combination product or kit of parts in the treatment of cancer; a method of treating cancer comprising administering the therapeutic combination, combination product or kit of parts to a patient. | 11-13-2014 |
Ada Hatzubai, Kibutz Palmah-Zova IL
Ada Lacayo, Lower Burrell, PA US
Patent application number | Description | Published |
---|---|---|
20110274799 | Mold Inhibiting Emulsion - A mold inhibiting emulsion including: an aqueous phase that includes water; a non-aqueous phase that may optionally include an oil; at least one emulsifier; and at least one mold inhibitor. Also provided is a method of inhibiting mold growth on edible baked products (e.g., bread) that involves applying the mold inhibiting emulsion of the present invention to the exterior surfaces of unbaked dough from which the edible baked product is prepared. The mold inhibiting emulsion may be applied to contact surfaces of a vessel in which dough is baked, and then to upper portions of the dough after it has been placed into the treated vessel. An apparatus for treating the exterior surfaces of unbaked dough with spray applied liquids, is further provided. The apparatus includes first and second spray stations each including a primary spray assembly and a secondary spray assembly activated if the primary spray assembly fails. | 11-10-2011 |
Ada Mbata, Lynnwood, WA US
Patent application number | Description | Published |
---|---|---|
20160115721 | SYSTEM AND METHOD FOR INTEGRATED MAGNETIC SLIDER ASSEMBLY FOR HANGING PARTITION - There is provided a system for an integrated magnetic slider assembly. The system has the integrated magnetic slider assembly with a slider portion, a hanger portion coupled to or integrated with the slider portion, and one or more magnets coupled to the hanger portion. The system further has a longitudinal hanging device configured for coupling to and suspending the slider portion of the integrated magnetic slider assembly. The system further has at least one hanging partition configured for coupling to the hanger portion of the integrated magnetic slider assembly, the at least one hanging partition having a plurality of pleats. All the magnets in a plurality of integrated magnetic slider assemblies are vertically aligned with respect to each other to cause a magnetic attraction between adjacent magnets in order to hold the plurality of pleats together, when the at least one hanging partition is in a retracted position. | 04-28-2016 |
Ada Repetto-Llamazares, Oslo NO
Patent application number | Description | Published |
---|---|---|
20160101199 | METHOD FOR UPREGULATING ANTIGEN EXPRESSION - The present invention relates to radioimmunoconjugates that are capable of upregulating expression of one or more antigens. The upregulated antigens can be the antigens that are targeted by the radioimmunoconjugates or different antigens expressed on the same cells. The present invention also relates to methods of treating cancer and diseases and disorders of the immune system by utilizing this enhanced expression of antigens. | 04-14-2016 |
Ada Rephaeli, Herzliya IL
Patent application number | Description | Published |
---|---|---|
20140024710 | 5-AMINOLEVULINIC ACID DERIVATIVES, METHODS FOR THEIR PREPARATION AND USES THEREOF - The present invention provides drug conjugates comprising 5-aminolevulinic acid (ALA), an aldehyde and a carboxylic acid that may function as a histone deacetylase inhibitor (HDACI). These conjugates may serve as co-drugs which release a plurality of active species in vivo. The novel drug conjugates may be used, for the treatment or prevention of cancer in PDT-dependent and/or PDT-independent (nonPDT) treatments, as well as for cosmetic uses. In addition the present invention provides novel uses for both the novel and known compounds. According to some embodiments, the present invention provides drug conjugates (co-drugs) comprising (i) ALA, (ii) an aldehyde and (iii) a carboxylic acid that may function as a histone deacetylase inhibitor (HDACO for the treatment of anemia and/or for the induction of erythropoiesis. | 01-23-2014 |
20150216830 | 5-AMINOLEVULINIC ACID DERIVATIVES, METHODS FOR THEIR PREPARATION AND USES THEREOF - There are provided conjugates comprising 5-aminolevulinic acid (5-ALA), an aldehyde and a carboxylic acid (e.g., a histone deacetylase inhibitor), compositions comprising same, methods for their preparation and uses thereof for treatment of cancer and anemia, and for inducing erythropoiesis. | 08-06-2015 |
Ada Skorodinsky, Livingston, NJ US
Patent application number | Description | Published |
---|---|---|
20080221336 | Pparalpha/Gamma Agonists and Processes of Preparing - This invention provides a method for preparing compounds having the structure [Formula (I)] wherein L is [Formula (A)] or [Formula (B)] in which R | 09-11-2008 |
Ada Solidar, Kansas City, MO US
Patent application number | Description | Published |
---|---|---|
20120295796 | System and Method of Predicting Chemical Interaction and Functionality of Molecules - A system and method of identifying a target molecule that bind to the bioactive site of a protein or protein complex is described. The system and method includes the steps of calculating the information signature of a first molecule that is known to bind to the bioactive site of a protein or protein complex, wherein the information signature is a string of numerical values based on the average distance and physico-chemical properties of each atom of a plurality of atoms in the first molecule, calculating the information signature of each target molecule in a library of target molecules, comparing the information signature of the first molecule to the information signatures of the target molecules, and selecting the target molecules having an information signature that is similar to the information signature of the first molecule. | 11-22-2012 |
20130203817 | Novel Inhibitors of LYN Kinase - The invention includes novel compounds that inhibit LYN kinase activity. The invention further includes a method of treating, ameliorating or preventing cancer in a subject in need thereof, wherein the cancer is dependent on LYN kinase activity. | 08-08-2013 |
Ada Solidar, Kanasa City, MO US
Patent application number | Description | Published |
---|---|---|
20130203789 | Novel Inhibitors of LYN Kinase and Methods Using Same - The invention includes compounds that inhibit LYN kinase activity. The invention further includes a method of treating, ameliorating or preventing cancer in a subject in need thereof, wherein the cancer is dependent on LYN kinase activity. | 08-08-2013 |
Ada Yonath, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20120316106 | SYNERGISTIC ANTIBIOTIC COMBINATIONS AND DERIVATIVES - Improved antibiotic analogs, and synergistic combinations of antibiotics designed based on structural crystallographic analysis, are provided as well as pharmaceutical compositions that include these improved analogs and synergistic combinations, along with methods for their production and use. The synergistic combinations target neighboring sites in the ribosome demonstrating the importance of the corresponding ribosomal sites for development of clinically-relevant synergistic antibiotics. | 12-13-2012 |
Ada Yonath, Rechovot IL
Patent application number | Description | Published |
---|---|---|
20090081697 | Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, and methods of rationally designing or identifying antibiotics using structure coordinate data derived from such crystals - Methods of growing crystals of free and antibiotic complexed large ribosomal subunits, coordinates defining the 3D atomic structure thereof and methods of utilizing such coordinates for rational design or identification of antibiotics or large ribosomal subunits having desired characteristics are disclosed. | 03-26-2009 |